Work underway to finalize expanded financing to fund development activities, potential deals, and operating scale-up.
Pipeline and expansion plans
Strategy includes evaluating CannEpil expansion into additional indications, alongside potential international market opportunities.
Pipeline buildout planned through reviews of additional cannabinoid formulations, including potential licensing, acquisitions, or strategic collaborations.
FDA submission and pre-submission meeting
Endovia Health Sciences set plans to submit a CannEpil Z package within a week, targeting an FDA-regulated development pathway.
A pre-submission conference request to the FDA is planned to clarify the product’s regulatory route and next-stage development steps.
EDVA•
